| Chlorobiales| Chlorobiales Gibbons and Murray 1978
Spore Formation: Firmicutes, including spore-forming genera like Amedibacillus, have the ability to form spores, which are resilient structures that can survive harsh conditions. In certain contexts, this spore-forming ability can be advantageous for the bacteria.
Environmental Roles: Bacteria in the Firmicutes phylum often play roles in nutrient cycling, decomposition of organic matter, and other ecological processes in environmental habitats such as soil and water.
Potential Industrial and Biotechnological Applications: Some bacteria within the Firmicutes phylum have been studied for their potential applications in industrial and biotechnological processes, such as the production of enzymes and other bioactive compounds.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 1.02 | 3 | 1140 | 0 | 733 | 193.6 | 70 | 275.1 | 0 | 450 | 0 %ile | 100 %ile | ||
biomesight | 77.16 | 0 | 160 | 30 | 370 | 0 | 1672 | 279.2 | 90 | 710.4 | 0 | 410 | 9.2 %ile | 90.8 %ile |
thorne | 100 | 15 | 373 | 0 | 224 | 75.1 | 45 | 75.8 | 27 | 107 | 0 %ile | 100 %ile | ||
thryve | 8.12 | 0 | 0 | 1 | 68 | 0 | 47 | 22 | 20 | 12.7 | 6 | 36 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 32.55 | 68.16 | 0.0033 | 0.0068 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
Biomesight | 82.631 % | 0.026 % | 0.068 % | 2450.0 | 2965 |
BiomeSightRdp | 74.194 % | 0.02 % | 0.026 % | 23.0 | 31 |
CerbaLab | 66.667 % | 0.001 % | 0 % | 2.0 | 3 |
custom | 8.197 % | 0.001 % | 0.001 % | 5.0 | 61 |
es-xenogene | 13.793 % | 0.032 % | 0.013 % | 4.0 | 29 |
Medivere | 28.571 % | 0.002 % | 0.001 % | 2.0 | 7 |
Thorne | 84.615 % | 0.004 % | 0.005 % | 88.0 | 104 |
Thryve | 7.902 % | 0.002 % | 0.001 % | 110.0 | 1392 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.